2 completed, 1 active not recruiting. 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Not applicable | 1 | Completed 1 |
Follow Anti-androgen: new trials by email Literature Review of Anti-androgen trials Research Report on Anti-androgen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor - Salivary Gland Cancer, Metastatic | Not applicable | Completed | University Health Network, Toronto | 114 | 2014-06-01 | 2026-01-08 |
| Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer GnRH agonist, Anti-androgen, TAK-700 - Prostate Cancer | Phase 3 | Completed | Radiation Therapy Oncology Group | 239 | 2012-05-01 | 2026-03-06 |
| Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer three-dimensional conformal radiotherapy, intensity modulated radiotherapy, Brachytherapy - Prostate Cancer | Phase 3 | Active not recruiting | Radiation Therapy Oncology Group | 2590 | 2011-07-01 | 2026-05-08 |
Prostatic Neoplasms (2) · Neoplasm Metastasis (1) · Neoplasms (1) · Recurrence (1) · Salivary Gland Neoplasms (1)
Radiation Therapy Oncology Group (2) · University Health Network, Toronto (1)
Canada (3) · United States (2) · Hong Kong (1) · Israel (1) · Singapore (1) · Switzerland (1)
Anna Spreafico (1) · M. Dror Michaelson, MD, PhD (1) · Mack Roach, MD (1)